NF-κB is essential for induction of CYLD, the negative regulator of NF-κB -: Evidence for a novel inducible autoregulatory feedback pathway

被引:162
作者
Jono, H
Lim, JH
Chen, LF
Xu, HD
Trompouki, E
Pan, ZXK
Mosialos, G
Li, JD
机构
[1] House Ear Res Inst, Gonda Dept Cell & Mol Biol, Los Angeles, CA 90057 USA
[2] Univ So Calif, Dept Otolaryngol, Los Angeles, CA 90057 USA
[3] Univ Calif San Francisco, Gladstone Inst Virol & Immunol, Dept Otolaryngol, San Francisco, CA 94141 USA
[4] Biomed Sci Res Ctr Alexander Fleming, Inst Immunol, Vari 16672, Greece
[5] Med Coll Ohio, Dept Microbiol & Immunol, Toledo, OH 43614 USA
关键词
D O I
10.1074/jbc.M406638200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The transcription factor NF-kappaB regulates genes involved in inflammatory and immune responses, tumorigenesis, and apoptosis. In contrast to the pleiotropic stimuli that lead to its positive regulation, the known signaling mechanisms that underlie the negative regulation of NF-kappaB are very few. Recent studies have identified the tumor suppressor CYLD, loss of which causes a benign human syndrome called cylindromatosis, as a key negative regulator for NF-kappaB signaling by deubiquitinating tumor necrosis factor (TNF) receptor-associated factor (TRAF) 2, TRAF6, and NEMO (NF-kappaB essential modulator, also known as IkappaB kinase gamma). However, how CYLD is regulated remains unknown. The present study revealed a novel autoregulatory feedback pathway through which activation of NF-kappaB by TNF-alpha and bacterium nontypeable Haemophilus influenzae (NTHi) induces CYLD that in turn leads to the negative regulation of NF-kappaB signaling. In addition, TRAF2 and TRAF6 appear to be differentially involved in NF-kappaB-dependent induction of CYLD by TNF-alpha and NTHi. These findings provide novel insights into the autoregulation of NF-kappaB activation.
引用
收藏
页码:36171 / 36174
页数:4
相关论文
共 21 条
[1]   Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB [J].
Brummelkamp, TR ;
Nijman, SMB ;
Dirac, AMG ;
Bernards, R .
NATURE, 2003, 424 (6950) :797-801
[2]   Duration of nuclear NF-κB action regulated by reversible acetylation [J].
Chen, LF ;
Fischle, W ;
Verdin, E ;
Greene, WC .
SCIENCE, 2001, 293 (5535) :1653-1657
[3]   Site-specific phosphorylation of I kappa B alpha by a novel ubiquitination-dependent protein kinase activity [J].
Chen, ZJ ;
Parent, L ;
Maniatis, T .
CELL, 1996, 84 (06) :853-862
[4]  
CHENG Q, 1994, J BIOL CHEM, V269, P13551
[5]   AUTOREGULATION OF I-KAPPA-B-ALPHA ACTIVITY [J].
CHIAO, PJ ;
MIYAMOTO, S ;
VERMA, IM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (01) :28-32
[6]   NF-κB in cancer:: From innocent bystander to major culprit [J].
Karin, M ;
Cao, YX ;
Greten, FR ;
Li, ZW .
NATURE REVIEWS CANCER, 2002, 2 (04) :301-310
[7]   The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination [J].
Kovalenko, A ;
Chable-Bessia, C ;
Cantarella, G ;
Israël, A ;
Wallach, D ;
Courtois, G .
NATURE, 2003, 424 (6950) :801-805
[8]  
Li QT, 2000, GENE DEV, V14, P1729
[9]   NF-κB regulation in the immune system [J].
Li, QT ;
Verma, IM .
NATURE REVIEWS IMMUNOLOGY, 2002, 2 (10) :725-734
[10]   IKK1-deficient mice exhibit abnormal development of skin and skeleton [J].
Li, QT ;
Lu, QX ;
Hwang, JY ;
Büscher, D ;
Lee, KF ;
Izpisua-Belmonte, JC ;
Verma, IM .
GENES & DEVELOPMENT, 1999, 13 (10) :1322-1328